EPIX - ESSA Pharma to Participate in Three Upcoming Investor Conferences

Canada NewsWire

VANCOUVER, Canada and HOUSTON, Texas , Nov. 8, 2021 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson , President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings at three upcoming virtual investor conferences. Peter Virsik , ESSA's Chief Operating Officer, and David S. Wood , ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.

Presentation Details

Event: Jefferies London Healthcare Conference
Format (on-demand): Fireside Chat
Date: Thursday, November 18, 2021
Time: 8:00 a.m. GMT / 3:00 a.m. ET

Event : Piper Sandler 33 ^rd Annual Healthcare Conference
Format (on-demand): Fireside Chat
Date: Monday, November 22, 2021
Time: 10 a.m. ET

Event : Evercore ISI 4 ^th Annual HealthCONx Virtual Conference
Format (on-demand): Fireside Chat
Date: Thursday, December 2, 2021
Time: 1:50 p.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com . Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma .

SOURCE ESSA Pharma Inc

View original content: http://www.newswire.ca/en/releases/archive/November2021/08/c2691.html